Samaya AI

The company trains its own financial language models rather than orchestrating someone else's, describing multiple specialised proprietary models that retrieve, contextualise and reason in tandem, and arguing explicitly that general purpose systems fail here because they produce generic output, hallucinate and hold static knowledge. Agents synthesise reports, build presentations from proprietary documents and reason across live sources. Apply the removal test and nothing operable remains.

Autonomy is the marketed capability at every level. Agents independently synthesise sector wide investment reports, build investment presentations from proprietary documents, and a further agent models the economy and produces quantitative predictions through multi stage reasoning without a person directing the steps. Cited evidence lets a professional check a claim, and that is the only control described.

No approval gate, confidence threshold, escalation path or review requirement appears anywhere, which matters because at the flagship customer this output feeds research delivered to clients rather than internal analysis.

Three things give a reviewer more than most of this lane offers. Outputs carry cited evidence and are described as auditable, so a claim can be traced rather than trusted. The model layer is purpose built with a stated orientation toward factuality, which is a design decision a validator can interrogate. And the company claims comparative benchmark results against general purpose tools, which at least concedes that performance should be measured. What is missing is the substance behind all three: no benchmark methodology or scores, no accuracy or error rates, no model documentation, and no stated support for a customer's own validation.

This is the strongest single reference in the capital markets group. A bulge bracket bank is named as a customer with its global director of research quoted on the record, describing a partnership across all divisions of the institutional securities group and confirming deployment in research, sales and trading and banking. Two further testimonials are attributed by role at a top five hedge fund and a top five asset manager.

The platform is described as live in production with thousands of users globally and 100 percent month on month usage growth, and the investor list includes a former technology chief executive, a Turing award winner and two senior financial services figures. Two claims deserve discounting rather than repetition: multiplying an analyst's output a thousandfold, and delivering no hallucinations.

The stated design orientation is unusual and correct for the domain: models trained for factuality over fluency and for financial expertise rather than generic responses, with outputs grounded in cited evidence and benchmarked against general purpose tools. That is a deliberate safety posture rather than a bolt on. Two things hold it back. Asserting no hallucinations is an absolute no system can support and sits awkwardly beside the grounding work that makes the product good.

And training custom models while holding a major bank's proprietary research library raises the cross customer boundary question more sharply than for retrieval based competitors, with nothing published to answer it.

Consumer privacy barely applies; the confidentiality exposure is institutional and substantial. The platform reasons over a bank's entire proprietary research library alongside external sources, and in banking and deal diligence workflows the material includes information that is price sensitive and restricted. No published privacy framework, data handling description, retention schedule or subprocessor list was located.

No trust centre, enumerated certification list, attestation scope or audit period was located in this pass. A deployment spanning all divisions of a bulge bracket institutional securities business would have required extensive independent assurance before proprietary research moved, so the published record substantially understates the control environment. The grade reflects what a prospective buyer can verify without entering procurement.

Samaya holds no licence and does not need one, but its deployment sits closer to a regulated artifact than any other vendor in this lane. Output is used inside a bank's research division to help create actionable insights for clients, and published investment research is governed by analyst conduct rules covering independence, disclosure, supervision and record keeping.

Nothing public addresses how machine generated content enters that process, what supervisory review applies, or how information barriers are maintained when one platform serves research, trading and banking at the same institution.

The subjects are markets and companies rather than people, so this reads as accuracy governance, and Samaya makes a comparative claim most competitors avoid, that benchmarks show stronger accuracy than tools built on general purpose models. No methodology, benchmark set or results were located to support it. Set against that is the assertion of no hallucinations, which cannot be evidenced and is the kind of claim that discourages the checking the product otherwise enables. Nothing describes where the agents degrade, how errors are detected once an output has entered a research note, or what accuracy looks like on the economic modelling agent.

Cited evidence attached to outputs is the practical recourse mechanism, letting an analyst verify a claim before it travels, and it is genuinely useful. The vendor stands behind nothing beyond it. Promising no hallucinations while offering no accuracy guarantee, remediation term or published error rate is the same tension seen elsewhere in this lane, and it is sharper here because the party ultimately exposed is the client of the bank, who receives research shaped by a system they will never know was involved.

The analytical layer is disclosed in more architectural detail than most, described as multiple specialised proprietary models that retrieve, contextualise and reason in tandem, custom trained for this domain. That tells a buyer the reasoning is owned rather than rented, which matters when the alternative in this lane is routing confidential deal material to an external provider.

The rest of the chain is closed: no infrastructure or hosting providers are named, no data or content sources are identified despite reasoning across millions of them, and no subprocessor list is published.

The ingestion claim is broad, covering proprietary document sets and millions of real time sources, and outputs are described as fitting the formats financial professionals already work in including generated investment presentations. Beneath that nothing is named.

No market data vendors, research management systems, document repositories or workflow platforms are identified as integrations, no public developer documentation or interface reference was located, and the deployment at a global bank across three divisions implies substantial custom integration work that is not described anywhere.

Delivery is cloud hosted with thousands of users globally. Residency and tenancy are the questions a bank asks before exposing its research library, and neither is answered: no hosting regions, no in country options, no description of whether a customer's proprietary corpus is isolated, no transfer mechanisms and no subprocessor list were located.

No rates, tiers, seat cost or minimum were located. The buyer set spans a global bank deploying across three divisions and individual hedge funds, which normally implies very different commercial structures, and nothing public indicates whether pricing follows seats, agents, query volume or enterprise agreement.

Coverage inside institutional securities is thorough and named by function rather than by slogan, spanning sell side research, sales and trading, investment banking, hedge funds, mutual funds and private markets, and the flagship deployment reaches three of those divisions at one institution simultaneously.

The boundary is the one this whole lane shares: nothing addresses commercial or retail banking, lending, payments, insurance or wealth platforms, so this is an institutional investment product rather than a financial services one.